The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.
Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...
Legislators may launch a study of how weight loss drugs might reduce costs in the Iowa Medicaid program. Jeffrey Boeyink is a ...
Senate Majority Leader Andrea Stewart-Cousins held a press conference with several other state senators to unveil a suite of legislation that’s supposed to cut costs and increase price ...
Using the database below, you can track changes in the average price pharmacies pay for prescription drugs. To find the ...
Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...
Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive press releases. In one, Lilly announced plans to acquire the farnesoid X ...
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
Eli Lilly is lowering the cost barrier to its weight loss drug Zepbound. For many consumers, their insurance denies them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results